MAPT and Alzheimer disease: Alzheimer’s disease (AD) is the most common dementia leading to progressive impairment of mental and physical functions and is neuropathologically identified by the presence of insoluble deposits of fibrillary plaques incorporating high amounts of amyloid-β peptide (Aβ) and tau fibrillary tangles [1].